Global Automation Engineering & Technology Head

OT Partner Enablement

OT Innovation & Capital Delivery Lead

Define and execute the global Operational Technology (OT) strategy and roadmap for manufacturing and QC systems, ensuring alignment with I&T and business strategies.

Advance paperless, recipe-driven, and data-integrated execution aligned to ISA-88/95 and Pharma 4.0 principles.

Prioritize OT initiatives that enhance productivity, regulatory compliance, and manufacturing reliability.

Communicate OT strategy, value realization, and roadmap progress to executive and site leadership.

Provide lifecycle ownership for Enterprise GxP manufacturing and lab OT platforms including OSI Pi, LIMS, Enterprise MES, Edge, Configuration management, and other enterprise tools

Provider governance and decisioning on Automation Systems (DCS/SCADA), MES, etc.

Ensure platforms meet operational, compliance, and performance standards across global sites.

Drive harmonization and modernization of Enterprise OT platforms and support the roadmap for site integrations.

Lead enterprise OT governance structures (Design Authority, Standards Council, etc.).

Define global OT standards for configuration, recipes, data, and cybersecurity in alignment with I&T, C&Q/CSV, GAMP 5 and GxP requirements.

Maintain validated, secure, and interoperable architectures between plant-level systems and enterprise data layers.

Ensure OT environments adhere to 21 CFR Part 11, Annex 11, and digital validation best practices.

Accountable for Tier 1 capital project delivery for manufacturing and QC digital platforms.

Govern Tier 2/3 site projects to ensure adherence to global OT standards, validation, and cybersecurity requirements.

Manage readiness, commissioning, and hypercare for OT systems introduced via T1 capital or digital programs.

Lead the global OT organization encompassing Lab Systems, Data Systems, Recipe Standards, and Innovation & Partner Enablement.

Operate as the OT Center of Excellence (CoE), defining best practices, playbooks, and training for site automation and lab teams.

Build global OT capabilities, talent pipelines, and competency frameworks.

Manage OT budgets (opex/capex) and resource allocation to maximize enterprise value.

Place a high priority on developing others through coaching, feedback, and developmental goals.

Provide a positive and equitable working environment, emphasizing values such as Customer Focus, Innovation, Integrity, Collaboration, and Superior Performance.

Develop and manage strategic partnerships with automation, MES, historian, and lab system platform provider (e.g., Siemens, Jag, Starlims, Aveeva (OSI) Pi).

Develop and manage strategic partnerships with integrator partners (Mescada, CapG, Avacone, Cognizant, etc.)

Align supplier roadmaps to OT strategy and ensure service excellence, cost optimization, and innovation delivery.

Establish joint governance with system integrators (SIs) and solution providers for lifecycle performance.

Leverage partner ecosystems to advance automation, edge computing, and digital manufacturing maturity.

Collaborate closely with I&T, Operations, Technical Operations, Quality, Validation, and Data Analytics while retaining ownership of the OT domain.

Ensure seamless data and integration flows between OT systems, enterprise layers, and cloud solutions under validated control.

Influence global and site leaders to adopt standardized OT processes, architectures, and governance.

Represent OT in enterprise risk, cybersecurity, and digital transformation forums.

Identify and pilot emerging OT and industrial digital technologies (AI/ML at the edge, digital twins, composable MES, Cloud, etc.).

Translate pilots into validated, scalable solutions that enhance reliability, compliance, and improve business outcomes.

Embed advanced analytics and process optimization into OT platforms.

Foster a culture of innovation and continuous improvement across the OT ecosystem.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .